Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
GH Research PLC - Ordinary Shares
(NQ:
GHRS
)
16.73
-0.01 (-0.06%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 23, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about GH Research PLC - Ordinary Shares
< Previous
1
2
3
4
5
6
7
8
9
...
18
19
Next >
Numinus Wellness, Seelos Therapeutics Among Top Psychedelic Movers Of Today
↗
March 08, 2023
Via
Benzinga
Cybin, GH Research Among Top Psychedelic Movers Of Today
↗
March 07, 2023
Via
Benzinga
Psyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & More
↗
March 07, 2023
Psychedelics Bills Around The Country: 9 New Proposals, Several Passes, Several Fails And A Successful Local Decriminalization Throughout the 2023 session, numerous discussions have been...
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 6, 2023
↗
March 06, 2023
Via
Benzinga
GH Resources: Focus On Treatment-Resistant Depression Paying Off
↗
March 06, 2023
A look at what GH Research is focused on, its latest quarterly financials, its stock price performance, and the price forecasts for the stock over the next 12 months.
Via
Talk Markets
Here Are The Year's Highest Priced Psychedelics Stocks In US Markets
↗
March 06, 2023
After everything that's happened in the last several years, we believe it's safe to say that the psychedelic renaissance is a reality, one that Benzinga has consistently reported on.
Via
Benzinga
Cybin, GH Research Among Top Psychedelic Movers Of Today
↗
March 03, 2023
Via
Benzinga
GH Research 2022 R&D Expenses Grow 138% To $20.5M, What About Net Loss?
↗
March 03, 2023
GH Research PLC (NASDAQ: GHRS) released its financial results for the full year ended December 31, 2022, revealing R&D expenses were $20.5 million, a 138% increase compared to $8.6 million for the full...
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 2, 2023
↗
March 02, 2023
Via
Benzinga
GH Research Reports Full Year 2022 Financial Results and Provides Business Updates
March 02, 2023
From
GH Research PLC
Via
GlobeNewswire
Cybin, GH Research Among Top Psychedelic Movers Of Today
↗
March 01, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 28, 2023
↗
February 28, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 27, 2023
↗
February 27, 2023
Via
Benzinga
Of The 6 Largest Psychedelic Drug Stocks, Only One Has Not Advanced YTD
↗
February 26, 2023
The most critical financial information on the health of a company is whether, or not, it has a Net Positive Operating Cash Flow; its Altman -Z Score; its Piotroski F-Score; and the percentage...
Via
Talk Markets
Psychedelic Stock Gainers And Losers From February 24, 2023
↗
February 24, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 23, 2023
↗
February 23, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 22, 2023
↗
February 22, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 21, 2023
↗
February 21, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 20, 2023
↗
February 20, 2023
Via
Benzinga
6 Largest Psychedelic Stocks Showing Strength; Up 11.5% YTD
↗
February 17, 2023
A look at the performance of the six largest psychedelic stocks by market capitalization.
Via
Talk Markets
ATAI Life Sciences, GH Research Among Top Psychedelic Movers Of Today
↗
February 17, 2023
Via
Benzinga
Cybin, Compass Pathways Among Top Psychedelic Movers Of Today
↗
February 16, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 15, 2023
↗
February 15, 2023
Via
Benzinga
GH Research, Mind Medicine Among Top Psychedelic Movers Of Today
↗
February 14, 2023
Via
Benzinga
Mind Medicine, GH Research Among Top Psychedelic Movers Of Today
↗
February 13, 2023
Via
Benzinga
"Rags-To-Riches" Portfolio Down 8% Last Week
↗
February 13, 2023
Our newest Portfolio consists of 14 cannabis, psychedelic and plant-based food stocks with market capitalizations of at least $400M. It's holding above water YTD but was not able to hang onto last...
Via
Talk Markets
Major Psychedelic Compound-Based Stocks UP 13% YTD
↗
February 11, 2023
We track the performance of the 6 largest companies researching the treatment of mental illnesses based on the use of one or more of 10 different psychedelic compound-based substances.
Via
Talk Markets
Cybin, Seelos Therapeutics Among Top Psychedelic Movers Of Today
↗
February 10, 2023
Via
Benzinga
Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today
↗
February 09, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 8, 2023
↗
February 08, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
18
19
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
